Intended Use
This kit is used to quantitatively detect the content of Golgi protein 73 (GP73) in human serum and plasma samples in vitro. It is mainly used for condition monitoring and curative effect evaluation of patients with liver cancer who have been histologically confirmed. It cannot be used as the basis for the early diagnosis or diagnosis of malignant tumors, and is not used for tumor screening of the general population.